
1. hematol oncol clin north am. 2018 feb;32(1):11-21. doi:
10.1016/j.hoc.2017.09.002.

castleman disease pathogenesis.

fajgenbaum dc(1), shilling d(2).

author information: 
(1)division translational medicine human genetics, hospital the
university pennsylvania, 3400 spruce street, silverstein 5, suite s05094,
philadelphia, pa 19104, usa. electronic address: davidfa@pennmedicine.upenn.edu.
(2)division translational medicine human genetics, hospital the
university pennsylvania, 3400 spruce street, silverstein 5, suite s05094,
philadelphia, pa 19104, usa.

castleman disease (cd) describes group heterogeneous disorders common
lymph node histopathologic features, including atrophic hyperplastic germinal 
centers, prominent follicular dendritic cells, hypervascularization, polyclonal
lymphoproliferation, and/or polytypic plasmacytosis. cause pathogenesis
of four subtypes cd (unicentric cd; human herpesvirus-8-associated
multicentric cd; polyradiculoneuropathy, organomegaly, endocrinopathy, monoclonal
plasma cell disorder, skin changes [poems]-associated multicentric cd; and
idiopathic multicentric cd) vary considerably. article provides summary of
our current understanding cause, cell types, signaling pathways, and
effector cytokines implicated pathogenesis subtype.

copyright Â© 2017 elsevier inc. rights reserved.

doi: 10.1016/j.hoc.2017.09.002 
pmid: 29157613  [indexed medline]

